• AKVANO® expand_more
  • Pharma expand_more
  • Business scope expand_more
  • Company expand_more
    • About expand_more
    • Management expand_more
    • CEO – letter expand_more
  • Investors expand_more
    • Investors expand_more
    • Investerare expand_more
  • Media expand_more
logo
  • AKVANO® expand_more
  • Pharma expand_more
  • Business scope expand_more
  • Company expand_more
    • About expand_more
    • Management expand_more
    • CEO – letter expand_more
  • Investors expand_more
    • Investors expand_more
    • Investerare expand_more
  • Media expand_more
Home / IR contact / IPO and prospectus / TO1
  • IR contact
  • Rights Issue 2024
  • Press releases
  • Financial reports
  • Financial calendar
  • Corporate governance
    • Annual General Meeting
    • Board of directors
    • Management
    • Certified Adviser
  • The share
    • Shareholders
    • Incentive program
  • IPO and prospectus
    • TO1
  • Presentations
  • Subscribe
Investor menu
  • IR contact
  • Rights Issue 2024
  • Press releases
  • Financial reports
  • Financial calendar
  • Corporate governance
    • Annual General Meeting
    • Board of directors
    • Management
    • Certified Adviser
  • The share
    • Shareholders
    • Incentive program
  • IPO and prospectus
    • TO1
  • Presentations
  • Subscribe

TO1


TO1 2019

Press release, October 14, 2020, in Swedish.

Press release, November 4, 2020, in Swedish.

Press release, November 11, 2020, in Swedish

 

The board of directors’ report, in Swedish  

Auditor’s opinion, in Swedish

logo

Technology

The AKVANO® platform

Pharma applications

Investors

Investor relations

Pressreleases

Business scope

Company

About

Management

Press

Contact

Contact page

info@lipidor.se

 

The information on this website is of general information nature and is not intended to replace personal medical advice from doctors and other healthcare professionals. Lipidor’s pharma products are investigational drugs and are not approved for commercial use.

Privacy policy

©2025 Lipidor AB. All rights reserved.